Literature DB >> 3905479

The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.

L G Thaete, R K Crouch, M G Buse, S S Spicer.   

Abstract

Copper-zinc superoxide dismutase is known to protect pancreatic beta-cell function from the damage of alloxan. A morphological investigation of copper-zinc superoxide dismutase prophylaxis against alloxan was undertaken in rats to investigate the mechanism of this protective action. Exogenous copper-zinc superoxide dismutase reproducibly protected the morphological features of pancreatic beta cells against damage by alloxan as determined by light microscopic immunostaining for insulin and by ultrastructural examination. By the same criteria, alpha and delta cells appeared unaffected by administration of a combination of alloxan and copper-zinc superoxide dismutase or either agent alone. Autoradiography after injection of 125I labelled copper-zinc superoxide dismutase into normal rats showed no evidence that the enzyme enters viable islet cells, suggesting an extracellular site of protection against alloxan.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905479     DOI: 10.1007/bf00291975

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

Review 1.  Drugs producing diabetes through damage of the insulin secreting cells.

Authors:  C C Rerup
Journal:  Pharmacol Rev       Date:  1970-12       Impact factor: 25.468

2.  Fine structure of the pancreatic islet cells of normal and alloxan treated bats (Eptesicus fuscus).

Authors:  R E Hinkley; P R Burton
Journal:  Anat Rec       Date:  1970-01

3.  Ultrastructural pancreatic beta-cell changes in rabbits after small and large doses of alloxan.

Authors:  K F Wellmann; B W Volk; S S Lazarus
Journal:  Diabetes       Date:  1967-04       Impact factor: 9.461

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Protective role of superoxide dismutase against diabetogenic drugs.

Authors:  S E Gandy; M G Buse; R K Crouch
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

6.  Alloxan and H2O2 action on glucose metabolism in cultured fibroblasts. Generation of oxygen-containing free radicals as a mechanism of alloxan action.

Authors:  F Ishibashi; B V Howard
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

7.  The inhibition of islet superoxide dismutase by diabetogenic drugs.

Authors:  R K Crouch; S E Gandy; G Kimsey; R A Galbraith; G M Galbraith; M G Buse
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

8.  Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator.

Authors:  L J Fischer; S A Hamburger
Journal:  Diabetes       Date:  1980-03       Impact factor: 9.461

9.  Rat superoxide dismutases. Purification, labeling, immunoassay, and tissue concentration.

Authors:  K Asayama; I M Burr
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

10.  Stereological study of endoplasmic reticulum, Golgi complex and secretory granules in the B-cells of normal and alloxan-treated mice.

Authors:  L Boquist; R Lorentzon
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979
View more
  2 in total

1.  Maternal zinc intake of Wistar rats has a protective effect in the alloxan-induced diabetic offspring.

Authors:  Parichehreh Yaghmaei; Hamideh Esfahani-Nejad; Ramesh Ahmadi; Nasim Hayati-Roodbari; Azadeh Ebrahim-Habibi
Journal:  J Physiol Biochem       Date:  2012-06-23       Impact factor: 4.158

2.  Alloxan cytotoxicity is highly potentiated by plasma membrane- and lysosomal-associated iron--a study on a model system of cultured J-774 cells.

Authors:  H Zhang; U T Brunk
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.